However, SATB2 expression has been identified as a useful marker for CRC diagnosis and distinguishing primary colorectal tumors from metastatic tumors, and further research is needed to establish its full clinical utility and potential therapeutic implications. Here, SATB2 is linked to colorectal neoplasm.